Sleep All Night

$15.97$191.64

Clear
SKU: 92/98 UPC: 8-55586-00092-6

Summary

SLEEP ALL NIGHT is a dietary and herbal supplement formulated to help your body return to the healthy and natural sleep patterns it needs to perform its major function of protecting you and your health.

Although it is a common problem, poor sleep can have severe consequences and is detrimental to your health. Sleep allows your body to heal and rejuvenate. It helps the body and brain function properly and can improve focus, memory and learning. Proper sleep also lowers your risk of heart disease, diabetes, stroke, dementia, and obesity.

Reestablishing healthy sleep patterns is the most powerful tool you can rely on to maintain good health and extend your life.

Despite all of the well documented health benefits of getting a good night’s sleep, quality and quantity of sleep are at an all-time low. For adults, at least 7 hours of sleep every night is crucial to a healthy mind and body.

For many people, good sleep practices and habits are not enough. If you require a little extra help to reestablish healthy sleep patterns and experience deep restorative sleep, then SLEEP ALL NIGHT is for you.

It takes years to develop poor sleep patterns, so it may take up to two weeks to correct these poor sleep patterns. Therefore, we recommend that you initially use SLEEP ALL NIGHT every night for 15 straight nights.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Product information

SLEEP ALL NIGHT is a dietary supplement that promotes deep restorative sleep by helping your body reestablish healthy and natural sleep patterns.

  • Fall asleep faster
  • Stay asleep longer
  • Wake-up alert and refreshed
  • Promotes deep restorative sleep
  • 100% drug free
  • Clinical strength formula

3 Caplets provide:

Vitamin B6 (Pyridozine HCL) 50 mg
Magnesium (Citrate & Oxide) 250 mg
Glycine 1200 mg
Valerian Root Extract (0.8% valerenic acids) 500 mg
Zizyphus Jujube Extract (2% saponins) 200 mg
Hops Extract 4:1 100 mg
Melatonin 3 mg

For promoting deep restorative sleep, there is mounting evidence for the value of each of the ingredients in Sleep All Night.

Valerian, a flowering grassland plant that may reduce the amount of time it takes to fall asleep and help you sleep better according to multiple studies. Magnesium is a mineral with wide-ranging effects in the body and is believed to be calming and influence some of the processes that promote sleep. Glycine is an amino acid enhances sleep and supports whole-body health. Hops extract from the flowering hops plant is well known for its relaxation and calming effect. Melatonin is a hormone that tells your body when it is time to head to bed. It is one of the most popular supplements among people struggling to fall asleep. Pyridoxyl-5-Phosphate, the active metabolite in vitamin B-6 is a crucial element of biosynthesis and plays an important role in various functions of the body such as metabolism at the cellular level, muscle growth and repair, mood regulation, sleep regulation and other executive functions. Studies show it positively impacts aspects of sleep. Zizyphus Jujube extract has been used for sleep issues in Traditional Chinese Medicine and is known for its calming and relaxation effect.

With Sleep All Night, you get the combined benefits of each ingredient in one formula to help you fall asleep faster and stay asleep longer by restoring healthy sleep patterns.

Other ingredients: Powdered Cellulose, Stearic Acid (Vegetable Grade), Acacia/Arabic Gum, Sodium Starch Glycolate, Silicon Dioxide, and Tangerine Oil.

Does Not Contain: Yeast, milk, corn, wheat, gluten, soy, salt, artificial flavorings or preservatives.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Ingredients

3 SLEEP ALL NIGHT Caplets provide:

Vitamin B6 (Pyridozine HCL) 50 mg
Magnesium (Citrate & Oxide) 250 mg
Glycine 1200 mg
Valerian Root Extract (0.8% valerenic acids) 500 mg
Zizyphus Jujube Extract (2% saponins) 200 mg
Hops Extract 4:1 100 mg
Melatonin 3 mg

Hops extract comes from the flowers (seed cones) of the hop plant Humulus lupulus. Hops has long been recognized for its relaxation and calming effect. Studies suggest Hops extract may help to improve sleep quality, shorten time to fall asleep and improve sleep brain wave patterns.

Valerian extract is a perennial herb native to North America, Asia and Europe. Studies show valerian may improve sleep quality with fewer night awakenings and greater sleep duration. Valerian is also known for stress reduction and is among the eight most widely used herbal supplements in the world.

Zizyphus Jujube extract is a fruit most frequently used for sleep problems in Traditional Chinese Medicine with little side-effects. It is also used for purposes related to gastrointestinal health and digestion and is also known for its relaxation and calming effect.

Glycine is an amino acid that enhances sleep and supports whole-body health. Early research on glycine and its essential role in sleep was published in 1989 and later in 2008. One of the ways in which glycine aids in sleep was clarified when it was discovered that glycine is responsible for the profound muscle relaxation that occurs during various stages of REM sleep. In another study, glycine improved sleep efficiency, reduced difficulty in falling asleep and enhanced sleep satisfaction.

Pyridoxyl-5-Phosphate – is the active metabolite of vitamin B6. Vitamin B-6 helps your body convert food energy into glucose, metabolize fats and proteins, and ensure proper function of your nervous system. With these various effects, there are ways in which your vitamin B-6 status may cause or contribute to your sleeping difficulties, or insomnia. Pyridoxine is considered adequate for neurotransmitter production to support sleep. Studies show that Pyridoxyl-5-Phosphate positively impacts aspects of sleep and is essential for promoting and maintaining a good mood.

Magnesium is involved in over 300 enzyme-related biochemical processes and appears to influence sleep in a variety of ways. Those who are deficient in magnesium are more likely to have abnormal EEG readings during sleep, more nocturnal awakenings, less time spent in stage 5 REM sleep and self-reports of poor sleep quality. On the other hand, those taking dietary magnesium supplements are more likely to experience better sleep efficiency, the ability to fall asleep faster, and the ability to reduce cortisol levels. Magnesium supplementation also helps to restore normal EEG patterns during sleep.

Melatonin is a hormone produced by the pineal gland that helps to control our body’s biorhythms and thereby helps to regulate sleep. It has become one of the most frequently used non-prescription sleep aids. Melatonin helps to promote total sleep time and can help balance circadian rhythm disruption.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Take 3 caplets 1 hour before bedtime.

Once you are falling asleep easily and consistently, you may cut back to 2 caplets per night.

Note: Taking the caplets with a small amount of slow digesting carbohydrates such as crackers, pinto or black beans can be helpful, as some people with sleep issues wake during the night due to a drop in bold sugar which these slow release carbs can help prevent.

Warnings: This product is not recommended for pregnant or lactating women or children under the age of 18. This product should not be used by anyone taking antidepressant drugs or in combination with prescription sedative drugs. This product should not be taken before driving a car or operating heavy machinery. As with all dietary supplements, consult with your physician before using.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Side Effects

Warnings: This product is not recommended for pregnant or lactating women or children under the age of 18. This product should not be used by anyone taking antidepressant drugs or in combination with prescription sedative drugs. This product should not be taken before driving a car or operating heavy machinery. As with all dietary supplements, consult with your physician before using.* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

References

  1. Benington JH, Heller HC. Restoration of brain energy metabolism as the function of sleep. Prog Neurobiol. 1995;45(4):347-360.
  2. Berger RJ, Phillips NH. Energy conservation and sleep. Behav Brain Res. 1995;69(1-2):65-73.
  3. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-377. doi:10.1126/science.1241224
  4. Siegel JM. Sleep viewed as a state of adaptive inactivity. Nat Rev Neurosci. 2009;10(10):747-753. doi:10.1038/nrn2697
  5. HHS. 1 in 3 adults don’t get enough sleep: A good night’s sleep is critical for good health. Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/media/releases/2016/p0215-enough-sleep.html. Published 2016.
  6. Akerstedt T, Philip P, Capelli A, Kecklund G. Sleep loss and accidents–work hours, life style, and sleep pathology. Prog Brain Res. 2011;190:169-188. doi:10.1016/B978-0-444-53817-8.00011-6
  7. Wade AG. The societal costs of insomnia. Neuropsychiatr Dis Treat. 2010;7:1-18. doi:10.2147/NDT.S15123
  8. Leger D, Massuel M-A, Metlaine A. Professional correlates of insomnia. Sleep. 2006;29(2):171-178.
  9. Malhotra RK. Neurodegenerative disorders and sleep. Sleep Med Clin. 2018;13(1):63-70. doi:10.1016/j.jsmc.2017.09.006
  10. Shi L, Chen S-J, Ma M-Y, et al. Sleep disturbances increase the risk of dementia: A systematic review and meta-analysis. Sleep Med Rev. 2018;40:4-16. doi:10.1016/j.smrv.2017.06.010
  11. Kawakami N, Takatsuka N, Shimizu H. Sleep disturbance and onset of type 2 diabetes. Diabetes Care. 2004;27(1):282-283.
  12. Bassetti CL. Sleep and stroke. Semin Neurol. 2005;25(1):19-32. doi:10.1055/s-2005-867073
  13. Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014;21(1):57-64. doi:10.1177/2047487312460020
  14. Um YH, Hong S-C, Jeong J-H. Sleep problems as predictors in attention- hyperactivity disorder: causal mechanisms, consequences and treatment. Clin Psychopharmacol Neurosci. 2017;15(1):9-18. doi:10.9758/cpn.2017.15.1.9
  15. Li Y, Zhang X, Winkelman JW, et al. Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation. 2014;129(7):737-746. doi:10.1161/CIRCULATIONAHA.113.004500
  16. Lin Y-K, Lin G-Y, Lee J-T, et al. Associations between sleep quality and migraine frequency: A cross-sectional case-control study. Medicine (Baltimore). 2016;95(17):e3554. doi:10.1097/MD.0000000000003554
  17. Wolk R, Gami AS, Garcia-Touchard A, Somers VK. Sleep and cardiovascular disease. Curr Probl Cardiol. 2005;30(12):625-662. doi:10.1016/j.cpcardiol.2005.07.002
  18. Malhotra A, Loscalzo J. Sleep and cardiovascular disease: an overview. Prog Cardiovasc Dis. 2009;51(4):279-284. doi:10.1016/j.pcad.2008.10.004
  19. Nagai, M, Hoshide, S, & Kario K. Sleep duration as a risk factor for cardiovascular disease – a review of the recent literature. Curr Cardiol Rev. 2010;6(1):54-61.
  20. How disrupted sleep may lead to heart disease. nih.gov. https://www.nih.gov/news-events/nih-research-matters/how-disrupted-sleep-may-lead-heart-disease. Published 2019. Accessed April 4, 2019.
  21. Lao X et al. Sleep quality, sleep duration, and the risk of coronary heart disease: A prospective cohort study with 60,586 adults. J Clin Sleep Med. 2018;14(1):109-117.
  22. Grandner, MA, Jackson, NJ, Pak, VM, & Gehrman P. Sleep disturbance is associated with cardvascular and metabolic disorders. J Sleep Res. 2012;21(4):427-433.
  23. Patyar S, Patyar RR. Correlation between Sleep Duration and Risk of Stroke. J Stroke Cerebrovasc Dis. 2015;24(5):905-911. doi:10.1016/j.jstrokecerebrovasdis.2014.12.038
  24. Koo DL, Nam H, Thomas RJ, Yun C-H. Sleep Disturbances as a Risk Factor for Stroke. J stroke. 2018;20(1):12-32. doi:10.5853/jos.2017.02887
  25. Sharma S, Culebras A. Sleep apnoea and stroke. Stroke Vasc Neurol. 2016;1(4):185-191. doi:10.1136/svn-2016-000038
  26. Ma C, Pavlova M, Liu Y, et al. Probable REM sleep behavior disorder and risk of stroke: A prospective study. Neurology. 2017;88(19):1849-1855. doi:10.1212/WNL.0000000000003902
  27. Phua CS, Jayaram L, Wijeratne T. Relationship between Sleep Duration and Risk Factors for Stroke. Front Neurol. 2017;8:392. doi:10.3389/fneur.2017.00392
  28. Ooms S, Overeem S, Besse K, Rikkert MO, Verbeek M, Claassen JAHR. Effect of 1 night of total sleep deprivation on cerebrospinal fluid beta-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol. 2014;71(8):971-977. doi:10.1001/jamaneurol.2014.1173
  29. Tarasoff-Conway JM, Carare RO, Osorio RS, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457-470. doi:10.1038/nrneurol.2015.119
  30. Rudnicka AR, Nightingale CM, Donin AS, et al. Sleep Duration and Risk of Type 2 Diabetes. Pediatrics. 2017;140(3). doi:10.1542/peds.2017-0338
  31. Shan Z, Ma H, Xie M, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2015;38(3):529-537. doi:10.2337/dc14-2073
  32. Tan X, Chapman CD, Cedernaes J, Benedict C. Association between long sleep duration and increased risk of obesity and type 2 diabetes: A review of possible mechanisms. Sleep Med Rev. 2018;40:127-134. doi:10.1016/j.smrv.2017.11.001
  33. Dutil C, Chaput J-P. Inadequate sleep as a contributor to type 2 diabetes in children and adolescents. Nutr Diabetes. 2017;7(5):e266. doi:10.1038/nutd.2017.19
  34. Lecube A, Romero O, Sampol G, et al. Sleep biosignature of Type 2 diabetes: a case-control study. Diabet Med. 2017;34(1):79-85. doi:10.1111/dme.13161
  35. Lee SWH, Ng KY, Chin WK. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis. Sleep Med Rev. 2017;31:91-101. doi:10.1016/j.smrv.2016.02.001
  36. Zhu B, Hershberger PE, Kapella MC, Fritschi C. The relationship between sleep disturbance and glycaemic control in adults with type 2 diabetes: An integrative review. J Clin Nurs. 2017;26(23-24):4053-4064. doi:10.1111/jocn.13899
  37. Reutrakul S, Mokhlesi B. Obstructive Sleep Apnea and Diabetes: A State of the Art Review. Chest. 2017;152(5):1070-1086. doi:10.1016/j.chest.2017.05.009
  38. Walsh JK, Coulouvrat C, Hajak G, et al. Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep. 2011;34(8):997-1011. doi:10.5665/SLEEP.1150
  39. Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45(7):904-910. doi:10.1111/j.1526-4610.2005.05159.x
  40. Sahota P. Morning headaches in patients with sleep disorders. Sleep Med. 2003;4(5):377.
  41. Seidel S, Hartl T, Weber M, et al. Quality of sleep, fatigue and daytime sleepiness in migraine – a controlled study. Cephalalgia. 2009;29(6):662-669. doi:10.1111/j.1468-2982.2008.01784.x
  42. Rasmussen BK. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain. 1993;53(1):65-72.
  43. van Oosterhout W, van Someren E, Schoonman GG, et al. Chronotypes and circadian timing in migraine. Cephalalgia. 2018;38(4):617-625. doi:10.1177/0333102417698953
  44. Spierings EL, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Headache. 2001;41(6):554-558.
  45. Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27(5):394-402. doi:10.1111/j.1468-2982.2007.01303.x
  46. Hvolby A. Associations of sleep disturbance with ADHD: implications for treatment. Atten Defic Hyperact Disord. 2015;7(1):1-18. doi:10.1007/s12402-014-0151-0
  47. Snitselaar MA, Smits MG, van der Heijden KB, Spijker J. Sleep and Circadian Rhythmicity in Adult ADHD and the Effect of Stimulants. J Atten Disord. 2017;21(1):14-26. doi:10.1177/1087054713479663
  48. Peppers KH, Eisbach S, Atkins S, Poole JM, Derouin A. An Intervention to Promote Sleep and Reduce ADHD Symptoms. J Pediatr Health Care. 2016;30(6):e43-e48. doi:10.1016/j.pedhc.2016.07.008
  49. Morash-Conway J, Gendron M, Corkum P. The role of sleep quality and quantity in moderating the effectiveness of medication in the treatment of children with ADHD. Atten Defic Hyperact Disord. 2017;9(1):31-38. doi:10.1007/s12402-016-0204-7
  50. Everitt H, Baldwin DS, Stuart B, et al. Antidepressants for insomnia in adults. Cochrane database Syst Rev. 2018;5:CD010753. doi:10.1002/14651858.CD010753.pub2
  51. Lu X-M, Zhu J-P, Zhou X-M. The effect of benzodiazepines on insomnia in patients with chronic obstructive pulmonary disease: a meta-analysis of treatment efficacy and safety. Int J Chron Obstruct Pulmon Dis. 2016;11:675-685. doi:10.2147/COPD.S98082
  52. Asnis GM, Thomas M, Henderson MA. Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians. Int J Mol Sci. 2015;17(1). doi:10.3390/ijms17010050
  53. Lie JD, Tu KN, Shen DD, Wong BM. Pharmacological Treatment of Insomnia. P T. 2015;40(11):759-771.
  54. Franco L, Sanchez C, Bravo R, Rodriguez A, Barriga C, Juanez JC. The sedative effects of hops (Humulus lupulus), a component of beer, on the activity/rest rhythm. Acta Physiol Hung. 2012;99(2):133-139. doi:10.1556/APhysiol.99.2012.2.6
  55. Ross SM. Sleep disorders: a single dose administration of valerian/hops fluid extract (dormeasan) is found to be effective in improving sleep. Holist Nurs Pract. 2009;23(4):253-256. doi:10.1097/HNP.0b013e3181aed09d
  56. Dimpfel W, Suter A. Sleep improving effects of a single dose administration of a valerian/hops fluid extract – a double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms. Eur J Med Res. 2008;13(5):200-204.
  57. Koetter U, Schrader E, Kaufeler R, Brattstrom A. A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Phytother Res. 2007;21(9):847-851. doi:10.1002/ptr.2167
  58. Schellenberg R, Sauer S, Abourashed EA, Koetter U, Brattstrom A. The fixed combination of valerian and hops (Ze91019) acts via a central adenosine mechanism. Planta Med. 2004;70(7):594-597. doi:10.1055/s-2004-827180
  59. Schmitz M, Jackel M. [Comparative study for assessing quality of life of patients with exogenous sleep disorders (temporary sleep onset and sleep interruption disorders) treated with a hops-valarian preparation and a benzodiazepine drug]. Wien Med Wochenschr. 1998;148(13):291-298.
  60. Muller-Limmroth W, Ehrenstein W. [Experimental studies of the effects of Seda-Kneipp on the sleep of sleep disturbed subjects; implications for the treatment of different sleep disturbances (author’s transl)]. Med Klin. 1977;72(25):1119-1125.
  61. Franco L, Sanchez C, Bravo R, et al. The sedative effect of non-alcoholic beer in healthy female nurses. PLoS One. 2012;7(7):e37290. doi:10.1371/journal.pone.0037290
  62. Dietz BM, Kang Y-H, Liu G, et al. Xanthohumol isolated from Humulus lupulus Inhibits menadione-induced DNA damage through induction of quinone reductase. Chem Res Toxicol. 2005;18(8):1296-1305. doi:10.1021/tx050058x
  63. Xin G, Wei Z, Ji C, et al. Xanthohumol isolated from Humulus lupulus prevents thrombosis without increased bleeding risk by inhibiting platelet activation and mtDNA release. Free Radic Biol Med. 2017;108:247-257. doi:10.1016/j.freeradbiomed.2017.02.018
  64. Plazar J, Zegura B, Lah TT, Filipic M. Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene (BaP), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and tert-butyl hydroperoxide (t-BOOH) in HepG2 human hepatoma cells. Mutat Res. 2007;632(1-2):1-8. doi:10.1016/j.mrgentox.2007.03.013
  65. Oxman AD, Flottorp S, Havelsrud K, et al. A televised, web-based randomised trial of an herbal remedy (valerian) for insomnia. PLoS One. 2007;2(10):e1040. doi:10.1371/journal.pone.0001040
  66. Pallesen S, Bjorvatn B, Nordhus IH, Skjerve A. [Valerian as a sleeping aid?]. Tidsskr Nor Laegeforen. 2002;122(30):2857-2859.
  67. Morris CA, Avorn J. Internet marketing of herbal products. JAMA. 2003;290(11):1505-1509. doi:10.1001/jama.290.11.1505
  68. Ni X, Shergis JL, Guo X, et al. Updated clinical evidence of Chinese herbal medicine for insomnia: a systematic review and meta-analysis of randomized controlled trials. Sleep Med. 2015;16(12):1462-1481. doi:10.1016/j.sleep.2015.08.012
  69. Rodriguez Villanueva J, Rodriguez Villanueva L. Experimental and clinical pharmacology of ziziphus jujuba mills. Phytother Res. 2017;31(3):347-365. doi:10.1002/ptr.5759
  70. Shergis JL, Ni X, Sarris J, et al. Ziziphus spinosa seeds for insomnia: A review of chemistry and psychopharmacology. Phytomedicine. 2017;34:38-43. doi:10.1016/j.phymed.2017.07.004
  71. Hsieh MT, Chen HC, Kao HC, Shibuya T. Suanzaorentang, and anxiolytic Chinese medicine, affects the central adrenergic and serotonergic systems in rats. Proc Natl Sci Counc Repub China B. 1986;10(4):263-268.
  72. Chen HC, Hsieh MT. Clinical trial of suanzaorentang in the treatment of insomnia. Clin Ther. 1985;7(3):334-337.
  73. Kwon H, Jung IH, Yi JH, et al. The Seed of Zizyphus jujuba var. spinosa Attenuates Alzheimer’s Disease-Associated Hippocampal Synaptic Deficits through BDNF/TrkB Signaling. Biol Pharm Bull. 2017;40(12):2096-2104. doi:10.1248/bpb.b17-00378
  74. Chase MH, Soja PJ, Morales FR. Evidence that glycine mediates the postsynaptic potentials that inhibit lumbar motoneurons during the atonia of active sleep. J Neurosci. 1989;9(3):743-751.
  75. Soja PJ. Glycine-mediated postsynaptic inhibition is responsible for REM sleep atonia. Sleep. 2008;31(11):1483-1486.
  76. Inagawa K et al. Subjective effects of glycine ingestion before bedtime on sleep quality. Sleep Biol Rythm. 2006;4:75-77.
  77. Yamadera W et al. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep Biol Rhythm. 2007;5:126-131.
  78. Inagawa K et al. Assessment of acute adverse events of glycine ingestion at a high dose in human volunteers. J Urban Living Heal Assoc. 2006;50:27-32.
  79. File SE, Fluck E, Fernandes C. Beneficial effects of glycine (bioglycin) on memory and attention in young and middle-aged adults. J Clin Psychopharmacol. 1999;19(6):506-512.
  80. Johansson S, Lindstedt S, Tiselius HG. Metabolic interconversions of different forms of vitamin B6. J Biol Chem. 1974;249(19):6040-6046.
  81. Russell RM. Factors in aging that effect the bioavailability of nutrients. J Nutr. 2001;131(4 Suppl):1359S-61S. doi:10.1093/jn/131.4.1359S
  82. Ebben M, Lequerica A, Spielman A. Effects of pyridoxine on dreaming: a preliminary study. Percept Mot Skills. 2002;94(1):135-140. doi:10.2466/pms.2002.94.1.135
  83. Morris MS, Sakakeeny L, Jacques PF, Picciano MF, Selhub J. Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status. J Nutr. 2010;140(1):103-110. doi:10.3945/jn.109.114397
  84. Friso S, Jacques PF, Wilson PW, Rosenberg IH, Selhub J. Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation. 2001;103(23):2788-2791.
  85. Sadeghi O, Nasiri M, Maghsoudi Z, Pahlavani N, Rezaie M, Askari G. Effects of pyridoxine supplementation on severity, frequency and duration of migraine attacks in migraine patients with aura: A double-blind randomized clinical trial study in Iran. Iran J Neurol. 2015;14(2):74-80.
  86. Popoviciu L et al. Clinical and Polysomnographic Researches in Patients with Sleep Disorders Associated with Magnesium Deficiencies. London: John Libbey; 1991.
  87. Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, Hedayati M, Rashidkhani B. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci. 2012;17(12):1161-1169.
  88. Nielson, FH, Johnson, LK, Zeng H. Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor sleep quality. Magesium Res. 2010;23(4):158-168.
  89. Tanabe K, Yamamoto A, Suzuki N, et al. Efficacy of oral magnesium administration on decreased exercise tolerance in a state of chronic sleep deprivation. Jpn Circ J. 1998;62(5):341-346.
  90. Held K, Antonijevic IA, Kunzel H, et al. Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry. 2002;35(4):135-143. doi:10.1055/s-2002-33195
  91. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci. 2004;1035:104-116. doi:10.1196/annals.1332.007
  92. Dibaba DT, Xun P, He K. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review. Eur J Clin Nutr. 2014;68(4):510-516. doi:10.1038/ejcn.2014.7
  93. Wagner J, Wagner ML, Hening WA. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacother. 1998;32(6):680-691. doi:10.1345/aph.17111
  94. Pandi-Perumal SR, Srinivasan V, Spence DW, Cardinali DP. Role of the melatonin system in the control of sleep: therapeutic implications. CNS Drugs. 2007;21(12):995-1018. doi:10.2165/00023210-200721120-00004
  95. Pevet P, Challet E. Melatonin: both master clock output and internal time-giver in the circadian clocks network. J Physiol Paris. 2011;105(4-6):170-182. doi:10.1016/j.jphysparis.2011.07.001
  96. Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol. 2011;53(9):783-792. doi:10.1111/j.1469-8749.2011.03980.x
  97. Brzezinski A, Vangel MG, Wurtman RJ, et al. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev. 2005;9(1):41-50. doi:10.1016/j.smrv.2004.06.004
  98. Karasek M. Melatonin, human aging, and age-related diseases. Exp Gerontol. 2004;39(11-12):1723-1729. doi:10.1016/j.exger.2004.04.012
  99. Ebrahimi-Monfared M, Sharafkhah M, Abdolrazaghnejad A, Mohammadbeigi A, Faraji F. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial. Restor Neurol Neurosci. 2017;35(4):385-393. doi:10.3233/RNN-160704
  100. Abdelgadir, IS, Gordon, MA, & Akobeng A. Melatonin for the management of sleep problems in children with neurodevelopmental disorders: A systematic review and meta-analysis. Drug Ther (NY). 2018;103(12):1163-1167.
  101. Janjua I, Goldman RD. Sleep-related melatonin use in healthy children. Can Fam Physician. 2016;62(4):315-317.
  102. Parker A, Beresford B, Dawson V, et al. Oral melatonin for non-respiratory sleep disturbance in children with neurodisabilities: systematic review and meta-analyses. Dev Med Child Neurol. February 2019. doi:10.1111/dmcn.14157
  103. Poeggeler B, Reiter RJ, Tan DX, Chen LD, Manchester LC. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res. 1993;14(4):151-168.
  104. Mayo JC, Sainz RM, Tan D-X, et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol. 2005;165(1-2):139-149. doi:10.1016/j.jneuroim.2005.05.002
  105. Carrillo-Vico A, Reiter RJ, Lardone PJ, et al. The modulatory role of melatonin on immune responsiveness. Curr Opin Investig Drugs. 2006;7(5):423-431.
  106. Bielli A, Scioli MG, Mazzaglia D, Doldo E, Orlandi A. Antioxidants and vascular health. Life Sci. 2015;143:209-216. doi:10.1016/j.lfs.2015.11.012
  107. Lundmark PO, Pandi-Perumal SR, Srinivasan V, Cardinali DP, Rosenstein RE. Melatonin in the eye: implications for glaucoma. Exp Eye Res. 2007;84(6):1021-1030. doi:10.1016/j.exer.2006.10.018
  108. Kozirog M, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel M. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res. 2011;50(3):261-266. doi:10.1111/j.1600-079X.2010.00835.x
  109. Mayo JC, Sainz RM, Antoli I, Herrera F, Martin V, Rodriguez C. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci. 2002;59(10):1706-1713.

Reviews

There are no reviews yet.

Be the first to review “Sleep All Night”

Your email address will not be published. Required fields are marked *